GlassScriptPhysician profile
Matthew B Sellers
NPI 1528225356
$31,037.50
in general payments reported to CMS, 2019-2025
38 companies · $1,701 in 2025
The $1,701 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $4,662 · 2021: $2,344 · 2022: $2,249 · 2023: $2,479 · 2024: $3,408 · 2025: $1,701.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,687 · Travel and Lodging: $1,901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,687.23 |
| Travel and Lodging | $1,900.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $14,240.85 | 2019-2023 | Xarelto |
| Biosense Webster, INC. | $4,406.00 | 2019-2025 | Carto 3, Soundstar |
| Boston Scientific Corporation | $4,289.51 | 2019-2025 | Watchman Flx, Farapulse, Watchman Access System |
| Biotronik INC. | $2,741.60 | 2019-2025 | Acticor 7 Vr-T Dx, Amvia Edge, Selectra |
| Medical Device Business Services, INC. | $957.48 | 2024 | Carto 3 |
| Cardiva Medical, INC. | $909.06 | 2020-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Abbott Laboratories | $760.44 | 2019-2024 | Confirm Rx, Aveir |
| Atricure, INC. | $371.52 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Novartis Pharmaceuticals Corporation | $354.90 | 2019-2023 | |
| Medtronic, INC. | $323.42 | 2021-2025 | Micra, Symplicity G3, Onyx Frontier |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $311.04 | 2019-2025 | Lifevest |
| Amgen INC. | $251.95 | 2019-2023 | Repatha |
| Sanofi-Aventis U.S. LLC | $136.72 | 2019 | |
| Merit Medical Systems INC | $131.98 | 2023 | Worley Adv Coronary Sinus Guide, Safeguard Focus |
| Edwards Lifesciences Corporation | $111.09 | 2019 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Sellers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.